Is Bioceres Crop Solutions Corp. overvalued or undervalued?

As of 21 May 2025, the valuation grade for Bioceres Crop Solutions Corp. has moved from expensive to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its current metrics, particularly with an EV to EBITDA ratio of 8.96 and an EV to Sales ratio of 0.86, which suggest that investors are paying a premium relative to its earnings and sales. In comparison, peers such as Oil-Dri Corp. of America, which has a P/E ratio of 25.16, and LSB Industries, Inc., with an EV to EBITDA of 12.51, highlight the relative riskiness of Bioceres's valuation.
The company's stock has underperformed significantly against the S&P 500, with a year-to-date return of -70.89% compared to the index's 12.22%. This stark contrast reinforces the notion that Bioceres is currently overvalued in the market.